期刊文献+

基于“心-肾-髓-以通为养”理论探讨中医药调控间充质干细胞治疗心肌缺血再灌注损伤的研究进展

Research Progress on Traditional Chinese Medicine Regulating Mesenchymal Stem Cells in the Treatment of Myocardial Ischemia-Reperfusion Injury Based on the"Heart-Kidney-Marrow Regulation with the Principle of Unblocking for Nourishment"Theory
原文传递
导出
摘要 心肌缺血再灌注损伤(MIRI)是心脏手术和介入治疗中常见的并发症,其发生机制复杂,涉及氧化应激、炎症反应、钙超载等多个方面。近年来,中医药在调控间充质干细胞(MSCs)治疗MIRI方面显示出独特的优势。文章综述了中医对MIRI的认识,探讨了“心-肾-髓-以通为养”理论在MIRI治疗中的应用,并分析了中医药调控MSCs治疗MIRI的可能机制,旨在为中医药在心肌保护领域的应用提供理论依据和实践指导。 Myocardial ischemia-reperfusion injury(MIRI)is a common complication in cardiac surgery and interventional therapy,with complex mechanisms involving oxidative stress,inflammatory response,calcium overload,and other factors.In recent years,traditional Chinese medicine(TCM)has demonstrated unique advantages in regulating mesenchymal stem cells(MSCs)for the treatment of MIRI.This article reviews the TCM perspective on MIRI,explores the application of the"heart-kidney-marrow regulation with the principle of unblocking for nourishment"theory in MIRI treatment,and analyzes potential mechanisms by which TCM regulates MSCs to alleviate MIRI.The aim is to provide theoretical foundations and practical guidance for the application of TCM in myocardial protection.
作者 张经财 魏巧卿 ZHANG Jingcai;WEI Qiaoqing(Department of Basic Medicine,School of Nursing and Health,Minjiang Teachers College,Fuzhou 350001,China;Department of Internal Medicine,Fuqing Hospital of Traditional Chinese Medicine,Fuzhou 350300,China)
出处 《延边大学医学学报》 2025年第3期37-40,共4页 Journal of Medical Science Yanbian University
关键词 心肌缺血再灌注损伤 中医药 间充质干细胞 心-肾-髓-以通为养 Myocardial ischemia-reperfusion injury traditional Chinese medicine mesenchymal stem cells heart-kidney-marrow regulation with the principle of unblocking for nourishment
  • 相关文献

参考文献25

二级参考文献299

共引文献230

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部